Prelude Therapeutics Incorporated PRLD

Set alert

3.78 USD -0.06 (-1.56%)

At closeNov 3, 2026, 4:01 PM EST

3.78 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

3.76 Day range 4.00

1.19 52-week range 6.63

Held by insiders 9.36%

Held by institutions 84.98%

Float held by institutions 93.76%

Institutions 101

Top institutional holders
Holder	% held	Shares	Value	Reported
Orbimed Advisors LLC.	30.14%	16,589,442	20.57M	Sep 29, 2024
Baker Bros. Advisors, LP	18.40%	10,123,824	12.55M	Sep 29, 2024
Deerfield Management Company, L.P. (Series C)	6.84%	3,766,120	4.67M	Sep 29, 2024
Boxer Capital, LLC	3.10%	1,708,187	2.12M	Sep 29, 2024
Price (T.Rowe) Associates Inc	1.99%	1,097,599	1.36M	Sep 29, 2024
Blackrock Inc.	1.92%	1,058,316	1.31M	Sep 29, 2024

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Price (T.Rowe) Health Sciences Fund	1.47%	809,844	1.00M	Sep 29, 2024
Vanguard Total Stock Market Index Fund	1.31%	720,427	893.33K	Sep 29, 2024
iShares Russell 2000 ETF	0.65%	358,702	444.79K	Oct 30, 2024
MFS New Discovery Fund	0.60%	327,699	406.35K	Aug 30, 2024
Vanguard Extended Market Index Fund	0.38%	207,507	257.31K	Sep 29, 2024
Price (T.Rowe) Small-Cap Value Fund	0.32%	178,089	220.83K	Sep 29, 2024

PRLD insiders
Insider	Relation	Latest transaction	Date	Shares held
BONITA DAVID P. M.D.	Director and Beneficial Owner of more than 10% of a Class of Security	Purchase	May 21, 2023	0
CHARDONNET LAURENT	Chief Financial Officer	Purchase	May 22, 2023	42,165
HUANG JANE	President	Conversion of Exercise of derivative security	Oct 3, 2024	63,341
LIM BRYANT DAVID	Chief Financial Officer	Purchase	Dec 18, 2024	27,400
ORBIMED ADVISORS, L.L.C.	Beneficial Owner of more than 10% of a Class of Security	Purchase	May 21, 2023	0
VADDI KRISHNA	Chief Executive Officer	Purchase	Dec 18, 2024	0

Held by funds